1. Home
  2. LXU vs OCS Comparison

LXU vs OCS Comparison

Compare LXU & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$10.33

Market Cap

734.4M

Sector

Industrials

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$7.46

Market Cap

732.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXU
OCS
Founded
1968
2003
Country
United States
Switzerland
Employees
513
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
734.4M
732.4M
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
LXU
OCS
Price
$10.33
$7.46
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$13.00
★ $36.73
AVG Volume (30 Days)
★ 648.7K
291.2K
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 225.93
N/A
EPS
★ 0.18
N/A
Revenue
★ $615,208,000.00
N/A
Revenue This Year
$8.91
N/A
Revenue Next Year
N/A
$365.20
P/E Ratio
$58.53
★ N/A
Revenue Growth
★ 17.77
N/A
52 Week Low
$8.12
$7.11
52 Week High
$17.22
$34.48

Technical Indicators

Market Signals
Indicator
LXU
OCS
Relative Strength Index (RSI) 53.95 24.99
Support Level $10.35 N/A
Resistance Level $11.23 $13.49
Average True Range (ATR) 0.35 0.44
MACD 0.09 -0.04
Stochastic Oscillator 72.36 10.97

Price Performance

Historical Comparison
LXU
OCS

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: